Overview

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan